Press Releases

Tower Cold Chain Unveils an Industry-First Container Design

Tower Cold Chain, a leader in passive temperature-controlled containers, has unveiled the KTEvolution 12, setting a new standard in small parcel solutions for pharmaceutical products, thanks to its unique plate design.

Ardena's Nanomedicines Facility Marks €20 Million Expansion with first GMP approval

CPHI North America experts ‘mid-sized domestic CDMOs need to invest in operational efficiencies to drive “real” reshoring’

Supply chain resilience and new partner sourcing to benefit from a boom in outsourcing in 2025

SYGNATURE DISCOVERY RECEIVES ECOVADIS AWARD FOR SUSTAINABLE EXCELLENCE

Voiant and Thirona announce commercial partnership for full scope services in imaging-based clinical trials for pulmonary diseases

Lindus Health Debuts "All-in-One Diagnostics CRO" Solution for Diagnostic Clinical Trials

https://www.prnewswire.com/news-releases/lindus-health-debuts-all-in-one-diagnostics-cro-solution-for-diagnostic-clinical-trials-302126728.html?tc=eml_cleartime Lindus Health Debuts "All-in-One Diagnostics CRO" Solution for Diagnostic Clinical Trials

ChargePoint to expand product range by investing in a dedicated multi-million-pound single-use manufacturing facility

Mundipharma acquires all assets and rights related to REZZAYO® (rezafungin), reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area

Novel Concepts Medical Announces a Breakthrough Colon Cancer Study

Novel Concepts Medical’s case study shows improvement in a colon cancer patient with metastases in his liver and shrinkage of his tumor size after using our plant-based treatment.

Cyclo Therapeutics, Inc. Announced the Start of its Phase 2b Study for Trappsol Cyclo to Treat Alzheimer's Disease, Aiming to Reduce Amyloid Beta and Tau

Scientists are always looking for ways to develop better medications or other therapies that can help slow down the progression of the disease or improve symptoms. This might involve testing new drugs in the lab or in clinical trials with people who have Alzheimer's.

CordenPharma & GENEPEP Celebrate Strong Collaboration Leveraging Peptide Drug Substance Discovery & Clinical Development Expertise

ProPharma Announces Certification as Medidata Rave EDC Accredited Partner

ProPharma, the world’s largest Research Consulting Organization (RCO), and the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, announced that it received accreditation as a CRO partner for Medidata Rave EDC. This milestone marks a significant enhancement in ProPharma's service offering and ability to develop robust, custom electronic data collection systems for clinical research studies.

AES Clean Technology sets new standards for cleanliness and efficiency in cleanrooms with the launch of its CleanLock Module

The CleanLock Module is an airlock solution for cleanroom environments. It offers contamination control, speed, and efficiency in project execution. The module integrates cleanroom finishes, lighting, airflow patterns, and door controls for a highly controlled environment.

Mundipharma and Vectura announce plans to reformulate flutiform® (fluticasone propionate/formoterol fumarate) pressurised metered-dose inhaler (pMDI) as a commitment to reducing the product’s carbon footprint

The two companies have entered into a collaboration agreement to continue the development work of incorporating an environmentally friendly propellant into the formulation of flutiform® (fluticasone propionate/formoterol fumarate) used in a pressurised metered-dose inhaler (pMDI).

PathAI Partners with Google Cloud to Transform Drug Discovery and Precision Medicine Through AI-Powered Pathology

PathAI, a global leader in AI-powered pathology, today announced a strategic partnership with Google Cloud at Bio-IT World Conference & Expo to help biopharma companies and anatomic pathology (AP) labs accelerate the adoption of AI and digital pathology.

Julie Blasingim Promoted to Chief Executive Officer of Univo IRB

Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer

Amerigo Scientific Supplies Environmental Sampling Bootie for Salmonella and Environment Monitoring

Cresset® Creates New Vice President Role to Lead their Artificial Intelligence (AI) Strategy

Drug discovery specialists Cresset have announced a major new hire in their senior leadership team with the appointment of Dr. Mutlu Dogruel as Vice President of AI Solutions.

Ace Neuroscience Unveils Integrated Drug Development Services for Stroke

Ace Neuroscience announces the launch of its integrated drug development services specifically designed for preclinical research on stroke.